CA1114371A - Substituted 2,3-alkylene bis (oxy) benzamides, their derivatives and preparation process - Google Patents

Substituted 2,3-alkylene bis (oxy) benzamides, their derivatives and preparation process

Info

Publication number
CA1114371A
CA1114371A CA283,994A CA283994A CA1114371A CA 1114371 A CA1114371 A CA 1114371A CA 283994 A CA283994 A CA 283994A CA 1114371 A CA1114371 A CA 1114371A
Authority
CA
Canada
Prior art keywords
benzodioxane
carboxamide
methyl
ethyl
pyrrolidylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA283,994A
Other languages
English (en)
French (fr)
Inventor
Michel Thominet
Claude Collignon
Jacques Acher
Gerard Bulteau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Original Assignee
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7623835A external-priority patent/FR2360305A1/fr
Application filed by Societe dEtudes Scientifiques et Industrielles de lIle de France SA filed Critical Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Application granted granted Critical
Publication of CA1114371A publication Critical patent/CA1114371A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA283,994A 1976-08-04 1977-08-03 Substituted 2,3-alkylene bis (oxy) benzamides, their derivatives and preparation process Expired CA1114371A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7623835A FR2360305A1 (fr) 1976-08-04 1976-08-04 Nouveaux 2,3-alkylene bis (oxy)benzamides substitues, leurs derives et leurs procedes de preparation
FR7623835 1976-08-04

Publications (1)

Publication Number Publication Date
CA1114371A true CA1114371A (en) 1981-12-15

Family

ID=9176558

Family Applications (1)

Application Number Title Priority Date Filing Date
CA283,994A Expired CA1114371A (en) 1976-08-04 1977-08-03 Substituted 2,3-alkylene bis (oxy) benzamides, their derivatives and preparation process

Country Status (37)

Country Link
JP (1) JPS57167914A (de)
AR (1) AR219709A1 (de)
AT (1) AT358034B (de)
AU (1) AU516033B2 (de)
BE (1) BE857350A (de)
BG (1) BG36496A3 (de)
CA (1) CA1114371A (de)
CH (1) CH629198A5 (de)
CS (1) CS216246B2 (de)
DD (1) DD133237A5 (de)
DE (1) DE2760414C2 (de)
DK (1) DK152366C (de)
EG (1) EG12716A (de)
ES (1) ES461175A1 (de)
FI (1) FI63938C (de)
GR (1) GR61351B (de)
HK (2) HK40382A (de)
HU (1) HU179064B (de)
IE (2) IE45647B1 (de)
IL (2) IL52644A0 (de)
IN (1) IN145473B (de)
LU (1) LU77897A1 (de)
MC (1) MC1154A1 (de)
MW (1) MW2077A1 (de)
NL (1) NL172063C (de)
NO (1) NO152133C (de)
NZ (1) NZ184816A (de)
OA (1) OA05728A (de)
PH (3) PH22114A (de)
PL (1) PL111071B1 (de)
PT (1) PT66865B (de)
RO (1) RO72963A (de)
SE (2) SE440776B (de)
SU (1) SU716523A3 (de)
YU (1) YU40005B (de)
ZA (1) ZA774701B (de)
ZM (1) ZM6077A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027098D0 (en) * 1990-12-13 1991-02-06 Beecham Group Plc Pharmaceuticals
US10083697B2 (en) 2015-05-27 2018-09-25 Google Llc Local persisting of data for selectively offline capable voice action in a voice-enabled electronic device
JP6452575B2 (ja) * 2015-08-19 2019-01-16 株式会社トクヤマ ミルタザピンの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1473829A (fr) * 1964-06-09 1967-03-24 Ile De France Nu-(tertiaire-aminoalkyl)-méthylène dioxybenzamides et leur préparation

Also Published As

Publication number Publication date
NL172063B (nl) 1983-02-01
DK152366B (da) 1988-02-22
ZA774701B (en) 1979-01-31
LU77897A1 (de) 1978-02-09
IN145473B (de) 1978-10-21
ATA569677A (de) 1980-01-15
YU40005B (en) 1985-06-30
PH22114A (en) 1988-06-01
SE7708849L (sv) 1978-02-05
AU2750777A (en) 1979-02-08
MC1154A1 (fr) 1978-04-17
OA05728A (fr) 1981-05-31
CS216246B2 (en) 1982-10-29
AT358034B (de) 1980-08-11
SE437027B (sv) 1985-02-04
GR61351B (en) 1978-10-26
DK346977A (da) 1978-02-05
DD133237A5 (de) 1978-12-20
PL200066A1 (pl) 1978-09-11
BE857350A (fr) 1978-02-01
HU179064B (en) 1982-08-28
NZ184816A (en) 1980-11-14
MW2077A1 (en) 1978-12-13
JPS57167914A (en) 1982-10-16
SE8206546L (sv) 1982-11-17
IE45647B1 (en) 1982-10-20
SU716523A3 (ru) 1980-02-15
AU516033B2 (en) 1981-05-14
EG12716A (en) 1979-09-30
ES461175A1 (es) 1978-12-01
IL66138A0 (en) 1982-09-30
PH17710A (en) 1984-11-19
AR219709A1 (es) 1980-09-15
HK40382A (en) 1982-09-24
DE2760414C2 (de) 1990-05-17
IL52644A0 (en) 1977-10-31
ZM6077A1 (en) 1979-05-21
PL111071B1 (en) 1980-08-30
NL172063C (nl) 1983-07-01
PT66865A (fr) 1977-08-01
HK40482A (en) 1982-09-24
SE440776B (sv) 1985-08-19
FI63938B (fi) 1983-05-31
CH629198A5 (fr) 1982-04-15
FI772362A (de) 1978-02-05
NO152133B (no) 1985-04-29
SE8206546D0 (sv) 1982-11-17
SE453390B (sv) 1988-02-01
NO772739L (no) 1978-02-07
IE802409L (en) 1978-02-04
IE45646L (en) 1978-02-04
YU188277A (en) 1983-01-21
DK152366C (da) 1988-07-25
NL7708616A (nl) 1978-02-07
PT66865B (fr) 1978-12-29
BG36496A3 (en) 1984-11-15
NO152133C (no) 1985-08-07
JPS6259090B2 (de) 1987-12-09
RO72963A (ro) 1981-11-24
PH18629A (en) 1985-08-23
IE45646B1 (en) 1982-10-20
FI63938C (fi) 1983-09-12

Similar Documents

Publication Publication Date Title
US4306072A (en) Substituted 2,3-alkylene bis (oxy)-4,5 (or 5,6) azimido benzamides and derivatives thereof
US3853915A (en) 9-or 10-halo-4h-benzo{8 4,5{9 cyclo-hepta{8 1,2-b{9 thiophen-4-ones
US4937246A (en) PAF antagonist, 1,4-disubstituted piperazine compounds and production thereof
JPH0616648A (ja) ベンゾイミダゾリル誘導体、これらの化合物を含む医薬組成物及びそれらの調製法
JPS6350354B2 (de)
JPS6332072B2 (de)
JPH0471914B2 (de)
US3845060A (en) 1-(1-(2,3-dihydro-2-benzofuryl)-alkyl)-4-aminohexahydroisonicotinic acid amides or nitriles
JPS6089469A (ja) アルド−スリダクテ−ス抑制剤としてのスピロ三環式芳香族スクシンイミド誘導体及びこれを用いた治療方法並びに薬剤組成物
CA1125657A (en) Derivatives of 1,2,3,3a,8,8a-hexadydropyrrolo ¬2,3-b| indole
CA1114371A (en) Substituted 2,3-alkylene bis (oxy) benzamides, their derivatives and preparation process
US3631103A (en) 5-(3'-alkoxy or halo-propylidene)-dibenzo (a d)cyclohepta(1 4 6)triene - 10-carboxylic acid amides
US3408353A (en) 1, 3, 4, 9b-tetrahydro-2h-indeno(1, 2-c)pyridine derivatives
US3679699A (en) CIS-2-ACETYL-1-METHYL-1,2,3,3a,4,9b-HEXAHYDRO {8 1{9 BENZOPYRANO {8 4,3-C{9 PYRAZOLE
US3590034A (en) Amides derived from piperazine-1-acetic acid and esters thereof and process for obtaining same
US4268512A (en) Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
US3631034A (en) Derivatives of 5-cinnamoyl benzofuran their process of preparation and their therapeutic utilization
PL69663B1 (de)
US3382250A (en) Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US4323503A (en) Substituted 2,3-alkylene di (oxy) benzamides and derivatives
US4022778A (en) 10-Aryl-1,2,3,4-tetrahydropyrazino(1,2-α)indole and derivatives thereof
US3503990A (en) 6-aryl-4,5,6,7-tetrahydro-4-oxoindole derivatives
Huckle et al. 4-Amino-2, 3, 4, 5-tetrahydro-1-benzoxepin-5-ols, 4-amino-2, 3, 4, 5-tetrahydro-1-benzothiepin-5-ols, and related compounds
GB1571447A (en) Substituted 2,3-alkyleneduoxybenzamides
US3573316A (en) 2-alkanoylmethyl - 1,3,4,9b - tetrahydro-2h-indeno(1,2-c) pyridine salts and intermediates therefor

Legal Events

Date Code Title Description
MKEX Expiry